These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
494 related articles for article (PubMed ID: 23407795)
1. Alloantibodies against the B subunit of plasma factor XIII developed in its congenital deficiency. Wada H; Souri M; Matsumoto R; Sugihara T; Ichinose A Thromb Haemost; 2013 Apr; 109(4):661-8. PubMed ID: 23407795 [TBL] [Abstract][Full Text] [Related]
2. Aggressive fatal case of autoimmune hemorrhaphilia resulting from anti-Factor XIII antibodies. Sugiyama H; Uesugi H; Suzuki S; Tanaka K; Souri M; Ichinose A Blood Coagul Fibrinolysis; 2013 Jan; 24(1):85-9. PubMed ID: 23183237 [TBL] [Abstract][Full Text] [Related]
4. Severe congenital factor XIII deficiency caused by novel W187X and G273V mutations in the F13A gene; diagnosis and classification according to the ISTH/SSC guidelines. Souri M; Biswas A; Misawa M; Omura H; Ichinose A Haemophilia; 2014 Mar; 20(2):255-62. PubMed ID: 24286209 [TBL] [Abstract][Full Text] [Related]
5. Factor XIII deficiency: complete phenotypic characterization of two cases with novel causative mutations. Katona É; Muszbek L; Devreese K; Kovács KB; Bereczky Z; Jonkers M; Shemirani AH; Mondelaers V; Ermens AA Haemophilia; 2014 Jan; 20(1):114-20. PubMed ID: 24118344 [TBL] [Abstract][Full Text] [Related]
6. Molecular modeling predicts structural changes in the A subunit of factor XIII caused by two novel mutations identified in a neonate with severe congenital factor XIII deficiency. Souri M; Yee VC; Fujii N; Ichinose A Thromb Res; 2012 Sep; 130(3):506-10. PubMed ID: 22633530 [TBL] [Abstract][Full Text] [Related]
7. Rapid immunochromatographic test for detection of anti-factor XIII A subunit antibodies can diagnose 90 % of cases with autoimmune haemorrhaphilia XIII/13. Osaki T; Sugiyama D; Magari Y; Souri M; Ichinose A Thromb Haemost; 2015 Jun; 113(6):1347-56. PubMed ID: 25740658 [TBL] [Abstract][Full Text] [Related]
8. Recombinant factor XIII prophylaxis is safe and effective in young children with congenital factor XIII-A deficiency: international phase 3b trial results. Kerlin BA; Inbal A; Will A; Williams M; Garly ML; Jacobsen L; Kearney SL J Thromb Haemost; 2017 Aug; 15(8):1601-1606. PubMed ID: 28581691 [TBL] [Abstract][Full Text] [Related]
9. Assessment of Factor XIII. Muszbek L; Katona É; Kerényi A Methods Mol Biol; 2017; 1646():277-293. PubMed ID: 28804836 [TBL] [Abstract][Full Text] [Related]
10. Coagulation factor XIII deficiency. Diagnosis, prevalence and management of inherited and acquired forms. Biswas A; Ivaskevicius V; Thomas A; Oldenburg J Hamostaseologie; 2014; 34(2):160-6. PubMed ID: 24503678 [TBL] [Abstract][Full Text] [Related]
11. A case of acquired FXIII deficiency with severe bleeding symptoms. Hayashi T; Kadohira Y; Morishita E; Asakura H; Souri M; Ichinose A Haemophilia; 2012 Jul; 18(4):618-20. PubMed ID: 22356719 [TBL] [Abstract][Full Text] [Related]
12. International registry on factor XIII deficiency: a basis formed mostly on European data. Ivaskevicius V; Seitz R; Kohler HP; Schroeder V; Muszbek L; Ariens RA; Seifried E; Oldenburg J; Thromb Haemost; 2007 Jun; 97(6):914-21. PubMed ID: 17549292 [TBL] [Abstract][Full Text] [Related]
13. Molecular mechanism of a mild phenotype in coagulation factor XIII (FXIII) deficiency: a splicing mutation permitting partial correct splicing of FXIII A-subunit mRNA. Mikkola H; Muszbek L; Laiho E; Syrjälä M; Hämäläinen E; Haramura G; Salmi T; Peltonen L; Palotie A Blood; 1997 Feb; 89(4):1279-87. PubMed ID: 9028951 [TBL] [Abstract][Full Text] [Related]
14. Congenital factor XIII deficiency in Pakistan: characterization of seven families and identification of four novel mutations. Borhany M; Handrkova H; Cairo A; Schroeder V; Fatima N; Naz A; Amanat S; Shamsi T; Peyvandi F; Kohler HP Haemophilia; 2014 Jul; 20(4):568-74. PubMed ID: 24329762 [TBL] [Abstract][Full Text] [Related]
15. [Congenital factor XIII deficiency required high-dose factor XIII concentrate in late pregnancy]. Takahashi T; Hatao K; Suzukawa M; Oji T Rinsho Ketsueki; 2007 May; 48(5):418-20. PubMed ID: 17571589 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of prophylactic treatment with plasma-derived factor XIII concentrate (human) in patients with congenital factor XIII deficiency. Ashley C; Chang E; Davis J; Mangione A; Frame V; Nugent DJ Haemophilia; 2015 Jan; 21(1):102-8. PubMed ID: 25377187 [TBL] [Abstract][Full Text] [Related]
17. Novel and recurrent mutations in the F13A1 gene in unrelated Korean patients with congenital factor XIII deficiency. Jang MA; Park YS; Lee KO; Kim HJ Blood Coagul Fibrinolysis; 2015 Jan; 26(1):46-9. PubMed ID: 25004025 [TBL] [Abstract][Full Text] [Related]
18. Severe inhibitor-negative acquired factor XIII/13 deficiency with aggressive subdural haemorrhage. Kawano H; Yamamoto D; Uchihashi Y; Wakahashi K; Kawano Y; Sada A; Minagawa K; Katayama Y; Kohmura E; Souri M; Ichinose A Blood Coagul Fibrinolysis; 2013 Sep; 24(6):638-41. PubMed ID: 23511901 [TBL] [Abstract][Full Text] [Related]
19. Targeted inactivation of the mouse locus encoding coagulation factor XIII-A: hemostatic abnormalities in mutant mice and characterization of the coagulation deficit. Lauer P; Metzner HJ; Zettlmeissl G; Li M; Smith AG; Lathe R; Dickneite G Thromb Haemost; 2002 Dec; 88(6):967-74. PubMed ID: 12529747 [TBL] [Abstract][Full Text] [Related]